Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
Showing page 298 |
first page | previous page | next page | last page |
Overall_Gscore | No. of Cancer Types | ||||
HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
CDKL3 | ENSG00000006837 | 0.28 | 0.00 | 1 | 0 |
ADAM2 | ENSG00000104755 | 0.00 | 0.00 | 0 | 0 |
MMP27 | ENSG00000137675 | 0.00 | 0.00 | 0 | 0 |
MYH6 | ENSG00000197616 | 0.00 | 0.00 | 0 | 0 |
TRPM5 | ENSG00000070985 | 0.00 | 0.00 | 0 | 0 |
COLEC10 | ENSG00000184374 | 0.00 | 0.00 | 0 | 0 |
PRDM12 | ENSG00000130711 | 0.00 | 0.00 | 0 | 0 |
ADAM7 | ENSG00000069206 | 0.00 | 0.00 | 0 | 0 |
CHRNA6 | ENSG00000147434 | 0.00 | 0.00 | 0 | 0 |
LYZL1 | ENSG00000120563 | 0.00 | 0.00 | 0 | 0 |
PZP | ENSG00000126838 | 0.00 | 0.00 | 0 | 0 |
CGA | ENSG00000135346 | 0.00 | 0.00 | 0 | 0 |
PSG1 | ENSG00000231924 | 0.00 | 0.00 | 0 | 0 |
ESRRB | ENSG00000119715 | 0.00 | 0.00 | 0 | 0 |
ABCA10 | ENSG00000154263 | 0.00 | 0.00 | 0 | 0 |
CATSPER3 | ENSG00000152705 | 0.28 | 0.00 | 1 | 0 |
TECTA | ENSG00000109927 | 0.00 | 0.00 | 0 | 0 |
GABRR1 | ENSG00000146276 | 0.00 | 0.00 | 0 | 0 |
SCN5A | ENSG00000183873 | 0.00 | 0.00 | 0 | 0 |
TLL2 | ENSG00000095587 | 0.00 | 0.00 | 0 | 0 |
Showing page 298 |
first page | previous page | next page | last page |